Akari Therapeutics (AKTX) Institutional Ownership $1.20 +0.01 (+0.42%) As of 01/17/2025 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Akari Therapeutics (NASDAQ:AKTX)CurrentInstitutional OwnershipPercentage5.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$88.95KNumber ofInstitutional Sellers(last 12 months)0 Get AKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AKTX Institutional Buying and Selling by Quarter Akari Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/5/2024Omnia Family Wealth LLC87,628$273K0.1%+48.2%1.551% 11/15/2023Sabby Management LLC178,091$703K0.5%-97.6%3.152% 11/14/2022Armistice Capital LLC4,290,000$2.70M0.0%N/A5.762% 10/27/2022Omnia Family Wealth LLC782,372$493K0.4%+3.2%1.051% 5/6/2022Omnia Family Wealth LLC758,144$910K0.6%+13.7%1.277% 4/13/2022Hikari Power Ltd130,821$157K0.0%+45.7%0.220% 2/10/2022Wsfs Capital Management LLC100,000$150K0.1%N/A0.193% 2/4/2022Omnia Family Wealth LLC667,085$1.00M0.6%+42.8%1.285% 8/13/2021Renaissance Technologies LLC151,396$262K0.0%+14.0%0.318% 8/6/2021HighTower Advisors LLC26,000$45K0.0%N/A0.055% 8/3/2021Omnia Family Wealth LLC467,085$808K0.5%+12.1%0.981% 5/21/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/18/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/17/2021HRT Financial LP16,087$42K0.0%N/A0.101% 5/13/2021Renaissance Technologies LLC132,751$350K0.0%+23.3%0.837% 5/12/2021Geode Capital Management LLC30,264$79K0.0%N/A0.191% 5/12/2021Omnia Family Wealth LLC416,584$1.10M0.8%+6.4%2.627% 2/16/2021Endurant Capital Management LP206,561$382K0.1%N/A1.303% 2/10/2021HighTower Advisors LLC26,000$49K0.0%+62.5%0.164% (Data available from 1/1/2016 forward) AKTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AKTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Akari Therapeutics shares: Sabby Management LLC ($703K), Omnia Family Wealth LLC ($273K).Learn more on AKTX's institutional investors. What percentage of Akari Therapeutics stock is owned by institutional investors? 5.06% of Akari Therapeutics stock is owned by institutional investors. Learn more on AKTX's institutional investor holdings. Which institutional investors have been buying Akari Therapeutics stock? The following institutional investors have purchased Akari Therapeutics stock in the last 24 months: Omnia Family Wealth LLC ($28.51K). How much institutional buying is happening at Akari Therapeutics? Institutional investors have bought a total of 28,511 shares in the last 24 months. This purchase volume represents approximately $88.95K in transactions. Which Akari Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Akari Therapeutics stock in the last 24 months: Sabby Management LLC ($7.21M). How much institutional selling is happening at Akari Therapeutics? Institutional investors have sold a total of 7,214,040 shares in the last 24 months. This volume of shares sold represents approximately $28.50M in transactions. Related Companies Black Diamond Therapeutics Institutional Ownership Instil Bio Institutional Ownership XBiotech Institutional Ownership Aligos Therapeutics Institutional Ownership Tenaya Therapeutics Institutional Ownership Leap Therapeutics Institutional Ownership Atossa Therapeutics Institutional Ownership Alto Neuroscience Institutional Ownership Inventiva Institutional Ownership Nuvectis Pharma Institutional Ownership This page (NASDAQ:AKTX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKTX Stock Alerts